These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review. Shi W, Huang X, Zhang S, Jiao Y. Clin Rheumatol; 2021 Jun; 40(6):2485-2490. PubMed ID: 33057918 [Abstract] [Full Text] [Related]
3. [A case of fulminant hepatic failure in Wilson's disease combined with systemic lupus erythematosus]. Kim TY, Lee SH, Kim TJ, Cho KR, Cho SC, Han SH, Yang SY, Chung YW, Sohn JH, Baik SH, Bae SC, Lee DH, Kee CS. Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):100-4. PubMed ID: 12499822 [Abstract] [Full Text] [Related]
4. Wilson's disease combined with systemic lupus erythematosus: a case report and literature review. Zhang Y, Wang D, Wei W, Zeng X. BMC Neurol; 2018 Jun 15; 18(1):85. PubMed ID: 29907136 [Abstract] [Full Text] [Related]
5. Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities? Dell'era L, Boati E, Nebbia G, Corona F. Minerva Pediatr; 2012 Feb 15; 64(1):55-7. PubMed ID: 22350045 [Abstract] [Full Text] [Related]
6. Systemic lupus erythematosus combined with Wilson's disease: a case report and literature review. Yang Z, Li Q, Liu S, Zong Z, Yu L, Sun S. BMC Pediatr; 2024 Apr 15; 24(1):253. PubMed ID: 38622515 [Abstract] [Full Text] [Related]
7. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case]. López-Guerra N, Alvarez Lario B, García-Moncó C, Peña Sagredo JL. Med Clin (Barc); 1987 Apr 04; 88(13):552-4. PubMed ID: 3586738 [No Abstract] [Full Text] [Related]
8. Co-occurrence of Wilson's disease and systemic lupus erythematosus: a case report and literature review. Xu L, Liu B, Liu Z, Tang N, She C, Wang J, Zang B, Yang Y. BMC Gastroenterol; 2021 May 21; 21(1):229. PubMed ID: 34020599 [Abstract] [Full Text] [Related]
9. Refractory liver dysfunction was remarkably improved with chelating agents of Wilson's disease, in a patient with systemic lupus erythematosus-like syndrome after a parvovirus B19 infection. Nameki S, Maeda Y, Shibahara T, Fukui J, Shimizu T, Bessho K, Fujiwara H. Mod Rheumatol Case Rep; 2021 Jan 21; 5(1):182-187. PubMed ID: 33019911 [Abstract] [Full Text] [Related]
10. Membranoproliferative glomerulonephritis in a patient with Wilson's disease. Ozçakar ZB, Ekim M, Ensari A, Kuloglu Z, Yüksel S, Acar B, Kirsaçlioglu C, Kansu A, Yalçinkaya F, Girgin N. J Nephrol; 2006 Jan 21; 19(6):831-3. PubMed ID: 17173260 [Abstract] [Full Text] [Related]
11. Mania as the first manifestation of Wilson's disease. Machado AC, Deguti MM, Caixeta L, Spitz M, Lucato LT, Barbosa ER. Bipolar Disord; 2008 May 21; 10(3):447-50. PubMed ID: 18402634 [Abstract] [Full Text] [Related]
12. [Lupus erythematosus due to penicillamine associated with Wilson's disease]. Boudin G, Pépin B, Godeau P, Vernant JC, Gouerou H. Ann Med Interne (Paris); 1971 Feb 21; 122(2):269-73. PubMed ID: 5579428 [No Abstract] [Full Text] [Related]
13. [A syndrome similar to systemic lupus erythematosus caused by penicillamine in patients with Wilson's disease]. Kalina P, Procházková L, Hauftová D. Bratisl Lek Listy; 1985 Sep 21; 84(3):336-40. PubMed ID: 4041939 [No Abstract] [Full Text] [Related]
14. Penicillamine and the SLE syndrome. Walshe JM. J Rheumatol Suppl; 1981 Sep 21; 7():155-60. PubMed ID: 6939878 [Abstract] [Full Text] [Related]
15. D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson's Disease. Antos AJ, Litwin T, Przybyłkowski A, Skowrońska M, Kurkowska-Jastrzębska I, Członkowska A. Neurol Neurochir Pol; 2021 Sep 21; 55(6):595-597. PubMed ID: 34704604 [No Abstract] [Full Text] [Related]
17. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A, Curiel B, Berkowitz D, Levine A, Sack J, Lorberboym M. J Pediatr; 2008 Dec 21; 153(6):864-6. PubMed ID: 19014823 [Abstract] [Full Text] [Related]
18. Wilson's disease. Psychiatric manifestations may be the clinical presentation. Jackson GH, Meyer A, Lippmann S. Postgrad Med; 1994 Jun 21; 95(8):135-8. PubMed ID: 8202418 [Abstract] [Full Text] [Related]
19. Penicillamine-related lichenoid dermatitis and utility of zinc acetate in a Wilson disease patient with hepatic presentation, anxiety and SPECT abnormalities. Leggio L, Ferrulli A, Mirijello A, Abenavoli L, Di Giuda D, Funiciello S, Rotoli M, Gasbarrini G, Addolorato G. Int J Immunopathol Pharmacol; 2007 Jun 21; 20(1):185-90. PubMed ID: 17346443 [Abstract] [Full Text] [Related]
20. Neurological Wilson's disease with refractory rickets. Kaur S, Maheshwari A, Aneja S, Patra S, Krishnamurthy S, Seth A. J Pediatr Endocrinol Metab; 2011 Jun 21; 24(3-4):185-6. PubMed ID: 21648288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]